Nitroglycerin improves chemotherapy outcomes in NSCLC

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1528, 2006-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib improves QOL in NSCLC

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 512, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Erlotinib improves QOL in NSCLC

By  

Inpharma, Vol. 1, Iss. 1557, 2006-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Dose-dense chemotherapy improves clinical outcomes in breast cancer

By  

Inpharma, Vol. 1, Iss. 1392, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Gemcitabine improves the outlook for NSCLC patients

By  

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Pharmacogenomics of platinum-based chemotherapy in NSCLC

By Hildebrandt Michelle AT   Gu Jian   Wu Xifeng  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 745-755

Informa Healthcare

Access to resources Recommend Favorite